Abstract
Protein-calorie malnutrition is commonly found in chronic CAPD patients and is a matter of concern since low serum albumin levels correlate with an increased risk of morbidity and mortality. Recognition of this link has therefore led to a growing interest in the efficacy of IPAA therapy as a possible treatment option. The present case study took place within a larger, ongoing clinical trial and outlines our experience of administering one exchange of 1.1% IPAA (Nutrineal, Baxter Healthcare Ltd) per day over 18 weeks to a patient identified as being protein malnourished.
Publication types
-
Case Reports
-
Clinical Trial
-
Randomized Controlled Trial
MeSH terms
-
Amino Acids / therapeutic use*
-
Blood Urea Nitrogen
-
Cross-Over Studies
-
Dialysis Solutions / therapeutic use*
-
Diet, Vegetarian / adverse effects*
-
Female
-
Humans
-
Infusions, Parenteral
-
Kidney Failure, Chronic / complications
-
Kidney Failure, Chronic / therapy
-
Middle Aged
-
Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
-
Protein-Energy Malnutrition / drug therapy*
-
Protein-Energy Malnutrition / etiology*
-
Protein-Energy Malnutrition / metabolism
-
Serum Albumin / deficiency*
Substances
-
Amino Acids
-
Dialysis Solutions
-
Serum Albumin